IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$82.31−1.14 (-1.37%)
Close on Nov 18, 2026Market cap $1.05BP/E 44.0Yield –
IRadimed revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
IRadimed's revenue for the twelve months ending Sep 30, 2026 was $89.34M, up 11.0% year over year. For fiscal 2025 it was $83.81M, up 14.4% from the year before. Over ten years it grew 10.2% a year on average. The highest annual figure on record is $83.81M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $83.81M | +14.4% |
| FY2024 | Dec 31, 2024 | $73.24M | +11.7% |
| FY2023 | Dec 31, 2023 | $65.56M | +23.0% |
| FY2022 | Dec 31, 2022 | $53.30M | +27.5% |
| FY2021 | Dec 31, 2021 | $41.81M | +31.8% |
| FY2020 | Dec 31, 2020 | $31.72M | -17.7% |
| FY2019 | Dec 31, 2019 | $38.52M | +26.5% |
| FY2018 | Dec 31, 2018 | $30.44M | +31.9% |
| FY2017 | Dec 31, 2017 | $23.08M | -29.0% |
| FY2016 | Dec 31, 2016 | $32.50M | +2.9% |
| FY2015 | Dec 31, 2015 | $31.59M | +101.8% |
| FY2014 | Dec 31, 2014 | $15.65M | +38.0% |
| FY2013 | Dec 31, 2013 | $11.34M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $24.20M | +14.2% |
| Q2 FY2026 | Jun 30, 2026 | $20.47M | +0.3% |
| Q1 FY2026 | Mar 31, 2026 | $21.98M | +12.6% |
| Q4 FY2025 | Dec 31, 2025 | $22.69M | +17.0% |
| Q3 FY2025 | Sep 30, 2025 | $21.20M | +15.7% |
| Q2 FY2025 | Jun 30, 2025 | $20.41M | +13.8% |
| Q1 FY2025 | Mar 31, 2025 | $19.51M | +10.9% |
| Q4 FY2024 | Dec 31, 2024 | $19.39M | +11.1% |
| Q3 FY2024 | Sep 30, 2024 | $18.33M | +11.0% |
| Q2 FY2024 | Jun 30, 2024 | $17.93M | +11.1% |
| Q1 FY2024 | Mar 31, 2024 | $17.60M | +13.7% |
| Q4 FY2023 | Dec 31, 2023 | $17.45M | +17.4% |
| Q3 FY2023 | Sep 30, 2023 | $16.50M | +23.1% |
| Q2 FY2023 | Jun 30, 2023 | $16.13M | +26.8% |
| Q1 FY2023 | Mar 31, 2023 | $15.48M | +25.7% |
| Q4 FY2022 | Dec 31, 2022 | $14.86M | +25.2% |
| Q3 FY2022 | Sep 30, 2022 | $13.41M | +22.9% |
| Q2 FY2022 | Jun 30, 2022 | $12.72M | +29.7% |
| Q1 FY2022 | Mar 31, 2022 | $12.31M | +33.5% |
| Q4 FY2021 | Dec 31, 2021 | $11.87M | +38.9% |
| Q3 FY2021 | Sep 30, 2021 | $10.91M | +41.7% |
| Q2 FY2021 | Jun 30, 2021 | $9.81M | +44.4% |
| Q1 FY2021 | Mar 31, 2021 | $9.22M | +6.3% |
| Q4 FY2020 | Dec 31, 2020 | $8.55M | -21.5% |
| Q3 FY2020 | Sep 30, 2020 | $7.70M | -22.7% |
| Q2 FY2020 | Jun 30, 2020 | $6.79M | -26.3% |
| Q1 FY2020 | Mar 31, 2020 | $8.68M | +2.8% |
| Q4 FY2019 | Dec 31, 2019 | $10.89M | +30.6% |
| Q3 FY2019 | Sep 30, 2019 | $9.96M | +30.8% |
| Q2 FY2019 | Jun 30, 2019 | $9.23M | +25.1% |
| Q1 FY2019 | Mar 31, 2019 | $8.44M | +18.7% |
| Q4 FY2018 | Dec 31, 2018 | $8.34M | +24.4% |
| Q3 FY2018 | Sep 30, 2018 | $7.61M | +33.8% |
| Q2 FY2018 | Jun 30, 2018 | $7.38M | +33.5% |
| Q1 FY2018 | Mar 31, 2018 | $7.11M | +37.7% |
| Q4 FY2017 | Dec 31, 2017 | $6.70M | +11.9% |
| Q3 FY2017 | Sep 30, 2017 | $5.69M | – |
| Q2 FY2017 | Jun 30, 2017 | $5.52M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.16M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.99M | – |
See a number that looks wrong?